An Evaluation of Peptide‐Bond Isosteres

Choudhary, Amit; Raines, Ronald T.

doi:10.1002/cbic.201100272

Cited by 217 publications

(184 citation statements)

References 108 publications

Supporting

Mentioning

180

Contrasting

Order By: Relevance

“…[1] Therefore, the use of modified proline isosteres [2] incorporated into peptidomimetics is of considerable value to medicinal chemists in the invention of new pharmacophores.…”

Section: Introductionmentioning

confidence: 99%

3‐Hydroxyazetidine Carboxylic Acids: Non‐Proteinogenic Amino Acids for Medicinal Chemists

et al. 2013

View full text Add to dashboard Cite

The formation from D-glucose of both enantiomers of 2,4-dideoxy-2,4-iminoribonic acid is the first chemical synthesis of unprotected 3-hydroxyazetidine carboxylic acids. The long-term stability of 3-hydroxyazetidine amides is established at acidic and neutral pH and implies their value as non-proteinogenic amino acid components of peptides, providing medicinal chemists with a new class of peptide isosteres. The structure of N,3-O-dibenzyl-2,4-dideoxy-2,4-imino-D-ribonic acid was established by X-ray crystallographic analysis. An N-methylazetidine amide derivative is a specific inhibitor of β-hexosaminidases at the micromolar level, and is only the second example of potent inhibition of any glycosidase by an amide of a sugar amino acid related to an iminosugar.

show abstract

“…[1] Therefore, the use of modified proline isosteres [2] incorporated into peptidomimetics is of considerable value to medicinal chemists in the invention of new pharmacophores.…”

Section: Introductionmentioning

confidence: 99%

3‐Hydroxyazetidine Carboxylic Acids: Non‐Proteinogenic Amino Acids for Medicinal Chemists

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Finally, we demonstrated strong immune responses after a single injection. This finding broadens the opportunity for these self-assembled particles to be used as a vaccine-delivery platform; for example, for therapeutic cancer vaccines where quick and strong immune response is required [49,50].…”

Section: Discussion N Methods Developmentmentioning

confidence: 95%

“…The PtBA synthesized via ATRP method is well characterized (high quality and purity) with polydispersity index of less than 1.12 (value of 1 represent monodispersed constructs) [46,47]. Successively, more derivatives of PtBA were reported, among which were the star and dendritic type PtBA polymers (Figure 6) [48,49]. These star and branched PtBA polymers can be further modified to accommodate multiple antigenic components, and thus can be used as the core for a vaccine construct [49].…”

Section: Acrylate Polymermentioning

confidence: 99%

“…Conjugation of these units to hydrophilic peptide antigens therefore resulted in amphiphilic compounds that are able to micellize (selfassemble) into small particulates [49,54]. These nanoparticles vaccines could therefore induce significant immune responses against the targeted diseases.…”

Section: Formulation Into Nanoparticlesmentioning

confidence: 99%

“…Successively, more derivatives of PtBA were reported, among which were the star and dendritic type PtBA polymers (Figure 6) [48,49]. These star and branched PtBA polymers can be further modified to accommodate multiple antigenic components, and thus can be used as the core for a vaccine construct [49]. …”

mentioning

confidence: 99%

See 2 more Smart Citations

The development of peptide-based subunit vaccines against Streptococcus pyogenes, Necator americanus and Schistosome mansoni

Fuaad¹

View full text Add to dashboard Cite

Immunization via the use of whole pathogen (or its biological component) has been one of the most successful public health interventions. Historically, Edward Jenner pioneered the modern vaccination in the late 17 th century and since; vaccine research has been evolving rapidly. The practice of conventional vaccination, with attenuated or killed pathogen, was accepted worldwide and with this strategy, protections against many diseases were established. Nevertheless, not all diseases can be prevented via the conventional vaccination approach. For example, there is no vaccine against group A streptococcus (GAS), hookworm or schistosome infection, although recent statistics shows that these diseases affect almost a billion people worldwide (i.e. high demand for vaccines). The conventional vaccination via the use of weakened or killed GAS pathogen could result in the development of fatal autoimmune diseases (i.e. rheumatic fever and rheumatic heart disease), while vaccination using whole hookworm or schistosome parasite failed to develop protection in human, despite these vaccines were successful in animal (murine and/or canine) models. Therefore, synthetic vaccination approach via the use of minimal pathologic component (subunit peptide) necessary to stimulate immune response has the potential to address the drawbacks of using conventional vaccination approach. However, as peptides are poor immunogens on their own, the approach necessitates the use of adjuvants (immunostimulant) or carrier molecules to boost the vaccines' immunogenicity.In this PhD research project, novel carrier systems/delivery platforms were utilized for the development of synthetic (subunit) vaccines against three pathogens: Streptococcus pyogenes (GAS), Necator americanus (hookworm) and Schistosoma mansoni (schistosome). Two types of acrylate polymers, linear-and dendritic-poly(t-butyl)acrylate (PtBA), were used for the GAS vaccine development project while the lipid core peptide (LCP) systems were used for the development of self-adjuvanting vaccines against hookworm and schistosome infections. This research work mainly involved the design of peptide epitope, the synthesis of the subunit peptide and the delivery platforms, the conjugation peptides to the delivery platforms and immunological evaluation of the vaccine candidates in (inbred) mice model.In summary:• The synthetic pathway to produce self-assembled polymer-peptide hybrid vaccines via copper catalysed azide-alkyne cycloaddition (CuAAC) reaction was established for the development of vaccine candidates against GAS. The candidates were able to form ii distinct nanoparticles with sizes of 500 nm and 20 nm, for the linear-and dendriticPtBA, respectively. The conjugates were able to stimulate IgG secretion against J14peptide after a single-dose immunization, without the use of additional adjuvant.• Vaccines that are able to stimulate the humoral response (production of neutralizing antibodies) are vital for the development of therapeutics against hookworm infection.Alternative ap...

show abstract

Synthetic Approaches towards Peptidomimetic Design

Trabocchi

Guarna

2014

Peptidomimetics in Organic and Medicinal Chemistry

View full text Add to dashboard Cite

An Evaluation of Peptide‐Bond Isosteres

Cited by 217 publications

References 108 publications

3‐Hydroxyazetidine Carboxylic Acids: Non‐Proteinogenic Amino Acids for Medicinal Chemists

3‐Hydroxyazetidine Carboxylic Acids: Non‐Proteinogenic Amino Acids for Medicinal Chemists

The development of peptide-based subunit vaccines against Streptococcus pyogenes, Necator americanus and Schistosome mansoni

Synthetic Approaches towards Peptidomimetic Design

Contact Info

Product

Resources

About